Myeloma Cast Nephropathy: Causes, Symptoms and Specialist Kidney Treatment in Bangalore

Introduction

Many people with multiple myeloma develop kidney changes at some point, and these can often appear early in the course of the illness. Some notice swelling, tiredness, or changes in urine habits long before they realise their kidneys may be under strain. Research suggests that kidney involvement appears in nearly one-third to one-half of patients with myeloma, and myeloma cast nephropathy is one of the most frequent causes.

Early attention can make a genuine difference. With timely diagnosis and treatment, many people recover at least part of their kidney function. At NU Hospitals, our nephrology and haematology teams work closely to manage this condition through coordinated, patient-focused care.

The information below explains what myeloma cast nephropathy is, what causes it, which symptoms to watch for, and how it is usually treated.

What Is Myeloma Cast Nephropathy

Multiple myeloma is a cancer of plasma cells. These abnormal cells release large amounts of free light chains, which are fragments of antibodies. The kidneys filter these proteins, but when the levels become too high, the light chains reach the kidney tubules in large quantities. Inside these tubules, they can combine with a natural protein made by the kidneys called Tamm-Horsfall protein. This mixture forms firm plugs known as casts.

These casts block the tubules, reduce urine flow, and irritate the surrounding tissue. Over time, this leads to reduced kidney function. If the protein load is very high or if other risk factors are present, kidney injury can develop quickly.

Causes of Myeloma Cast Nephropathy

Several factors increase the likelihood of cast formation in the kidneys:

• High levels of free light chains

This is the leading cause. The kidneys become overwhelmed when plasma cells produce large amounts of light chains.

• Interaction with Tamm-Horsfall protein

Once inside the tubules, light chains can bind to this protein, forming casts that obstruct urine flow.

• Dehydration

Low fluid intake makes it harder for the kidneys to flush out light chains. This increases the chance of cast formation.

• High calcium levels

Hypercalcemia, which is common in myeloma, worsens dehydration and can injure the kidneys.

• Medications that strain the kidneys

Certain pain medicines, some antibiotics and contrast used in scans may worsen kidney stress if light chains are already high.

• Advanced or relapsed myeloma

The more active the disease is, the greater the load of light chains entering the kidneys.

Symptoms of Myeloma Cast Nephropathy

Symptoms vary greatly. Some individuals have noticeable changes, while others feel relatively normal at first.

Common symptoms include:

• Increased tiredness or lack of energy

• Swelling in the legs or around the eyes

• Reduced urine output or urine that appears unusually dark or foamy

• Nausea, vomiting or poor appetite

• Confusion or difficulty concentrating when kidney injury is severe

• Excessive thirst, constipation or muscle weakness

Because kidney changes may be subtle, regular monitoring is crucial for anyone with multiple myeloma.

Diagnosis and Treatment

Doctors usually combine several tests to determine whether excess light chains are affecting the kidneys. These may include:

• Blood tests

Blood tests are performed to get an idea about how the kidneys are functioning. These tests can show changes in filtration, shifts in calcium levels, and whether free light chains are higher than expected, all of which help identify early kidney stress.

• Urine tests

A urine sample is checked to see whether any proteins are present that normally would not be present in large amounts. Finding light chains in the urine can be an important clue that the kidneys are struggling to handle the extra protein load.

• Ultrasound scan

A simple imaging study is often done to rule out a blockage or any structural problem that might explain the change in kidney function.

• Kidney biopsy when needed

If the diagnosis is still unclear, a small tissue sample may be taken. Under the microscope, specialists can see whether casts have formed inside the tubules.

Treatment Approach

The two primary goals are to control the underlying myeloma and protect the kidneys from further damage.

• Treating the myeloma

Modern therapy has improved outcomes for kidney-related myeloma. Regimens that include drugs such as Bortezomib reduce the production of free light chains, which allows the kidneys to recover.

• Hydration and supportive care

Adequate hydration helps the kidneys clear light chains. Doctors also manage high calcium levels and avoid medicines that may worsen kidney injury.

• Dialysis when needed

Some people may need dialysis if the kidneys slow down more than expected or if fluid and waste products begin to build up. This support is often temporary. Once treatment for myeloma starts to lower the light chain levels, the kidneys may begin to recover, and dialysis can sometimes be reduced or stopped. The need for dialysis varies widely from person to person and is guided by ongoing medical assessments.

• Continuous monitoring

People with myeloma cast nephropathy usually need frequent blood and urine checks. These tests show how well the kidneys are coping and whether the treatment is lowering the amount of light chains. Tracking these values helps the team understand how the kidneys are responding and make any adjustments in time. Many people notice improved kidney function once the protein load on the kidneys begins to fall.

When to See a Urologist or Nephrologist

It is essential to contact a kidney specialist if you have myeloma and notice any changes that seem unusual for you. This may include swelling around the legs, feet, or eyes, darker or foamy urine, persistent headaches, nausea, loss of appetite, or symptoms of high calcium, such as thirst or general weakness, or reduced urine volume.

You should also seek medical advice if routine blood tests show an increase in creatinine or any decline in kidney function, even if you feel well. Early assessment provides the best opportunity to protect kidney function.

Specialist Kidney Care at NU Hospitals

• Leaders in renal and urological care

NU Hospitals has built a strong reputation in Bangalore for managing complex kidney conditions, including those linked with multiple myeloma.

• Experienced specialists

Our nephrologists and haematologists work together to assess kidney function and myeloma activity. 

• Advanced diagnostic support

NU Hospitals is equipped with state-of-the-art infrastructure and modern diagnostic tools to conduct light chain tests, detailed kidney scans, and biopsy studies when required.

• Patient-Centred Holistic Treatment Plans

Care is not limited to the treatment period. Our specialists accompany patients through all stages, including early assessments, regular follow-ups and continued support after the primary treatment is completed.

• Ongoing follow-up

For patients with multiple myeloma, regular interval checkups should be nonnegotiable. Follow-ups help identify early signs of kidney involvement so that appropriate care can be initiated without delay, as delays can be dangerous.

• Focus on positive outcomes

Early specialist care can protect long-term kidney function and support better treatment results.